Skip to content

STERIS STE UNITED STATES — Revenue

Other geography segments

IRELAND
$38.2M

Similar metrics at other companies

Embecta Corp. logo
EMBCUnited States — Revenue
$95.4M-29.4%
ICU Medical logo
ICUIUNITED STATES — Revenue
$315.5M-18.7%
Sotera Health logo
SHCUnited States — Total net revenues
$157.39M+2.1%
KORU Medical Systems logo
KRMDUS — Revenue
$8.44M+17.1%
Acme United logo
ACUUnited States — Revenue
$43.77M+11.9%
MSA
MSAUnited States — Revenue
$235.84M-1.2%

Other financials

Income statement

See full
Revenue$1.6B+7.3%
Gross profit$697.2M+8.8%
Operating income$316.8M+46.6%
Net income$220.2M+51.2%
EPS (diluted)$2.24+52.4%

Balance sheet

See full
Cash & equivalents$439.6M+156%
Total debt$2.1B-10.3%
Total equity$7.2B+8.8%
Total assets$10.7B+5.8%

Cash flow

See full
Operating cash flow$335.4M+28.6%
CapEx$90.2M+27.2%
Free cash flow$245.2M+29.1%

Valuation

See full
Market cap$20.64B-7.5%
Enterprise value$22.28B-7.0%
P/E26.4×-8.1×
P/S3.5×-0.5×

Profitability

See full
Gross margin44.2%+0.2pp
Operating margin18.6%+2.7pp
Net margin13.2%+1.9pp
FCF margin16.4%+2.1pp

Returns & leverage

See full
Return on equity11.3%+1.8pp
Debt / equity0.3×-0.1×
Current ratio2.1×+0.1×

Where this comes from

Reported directly by STERIS in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: STERIS’s 10-K, filed May 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about STERIS's united states — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is STERIS's UNITED STATES — revenue?
STERIS (STE) reported UNITED STATES — revenue of $1.15B in Q1 2026.
How has STERIS's UNITED STATES — revenue changed year-over-year?
STERIS's UNITED STATES — revenue increased by 6.2% year-over-year, from $1.08B to $1.15B.
What is the long-term trend for STERIS's UNITED STATES — revenue?
Over 4 years (2022 to 2026), STERIS's UNITED STATES — revenue has grown at a 10.1% compound annual growth rate (CAGR), from $2.94B to $4.33B.
What does UNITED STATES — revenue mean?
This metric captures the total gross income generated from the sale of sterilization services, decontamination equipment, and related supplies within the United States geographic segment. It serves as a primary indicator of market demand and the company's competitive position in the domestic healthcare and biopharma sectors. Growth in this figure reflects successful market penetration, pricing power, or increased volume in infection prevention services.